165 related articles for article (PubMed ID: 1594223)
1. Intraocular recurrence of uveal melanoma after proton beam irradiation.
Gragoudas ES; Egan KM; Seddon JM; Walsh SM; Munzenrider JE
Ophthalmology; 1992 May; 99(5):760-6. PubMed ID: 1594223
[TBL] [Abstract][Full Text] [Related]
2. Long-term risk of local failure after proton therapy for choroidal/ciliary body melanoma.
Gragoudas ES; Lane AM; Munzenrider J; Egan KM; Li W
Trans Am Ophthalmol Soc; 2002; 100():43-8; discussion 48-9. PubMed ID: 12545676
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of uveal melanoma with iodine 125 plaques or proton beam therapy: indications and comparison of local recurrence rates].
Desjardins L; Lumbroso L; Levy C; Mazal A; Delacroix S; Rosenwald JC; Dendale R; Plancher C; Asselain B
J Fr Ophtalmol; 2003 Mar; 26(3):269-76. PubMed ID: 12746603
[TBL] [Abstract][Full Text] [Related]
4. Conservation treatment of the eye: Conformal proton reirradiation for recurrent uveal melanoma.
Marucci L; Lane AM; Li W; Egan KM; Gragoudas ES; Adams JA; Collier JM; Munzenrider JE
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1018-22. PubMed ID: 16376492
[TBL] [Abstract][Full Text] [Related]
5. Conservative treatment of uveal melanoma: local recurrence after proton beam therapy.
Munzenrider JE; Verhey LJ; Gragoudas ES; Seddon JM; Urie M; Gentry R; Birnbaum S; Ruotolo DM; Crowell C; McManus P
Int J Radiat Oncol Biol Phys; 1989 Sep; 17(3):493-8. PubMed ID: 2550395
[TBL] [Abstract][Full Text] [Related]
6. The risk of enucleation after proton beam irradiation of uveal melanoma.
Egan KM; Gragoudas ES; Seddon JM; Glynn RJ; Munzenreider JE; Goitein M; Verhey L; Urie M; Koehler A
Ophthalmology; 1989 Sep; 96(9):1377-82; discussion 1382-3. PubMed ID: 2550868
[TBL] [Abstract][Full Text] [Related]
7. Effects of proton beam irradiation on uveal melanomas: a comparative study of Ki-67 expression in irradiated versus non-irradiated melanomas.
Chiquet C; Grange JD; Ayzac L; Chauvel P; Patricot LM; Devouassoux-Shisheboran M
Br J Ophthalmol; 2000 Jan; 84(1):98-102. PubMed ID: 10611107
[TBL] [Abstract][Full Text] [Related]
8. Proton beam radiotherapy of uveal melanoma: Italian patients treated in Nice, France.
Mosci C; Mosci S; Barla A; Squarcia S; Chauvel P; Iborra N
Eur J Ophthalmol; 2009; 19(4):654-60. PubMed ID: 19551683
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant proton beam irradiation vs. adjuvant ruthenium brachytherapy in transscleral resection of uveal melanoma.
Böker A; Pilger D; Cordini D; Seibel I; Riechardt AI; Joussen AM; Bechrakis NE
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1767-1775. PubMed ID: 29907945
[TBL] [Abstract][Full Text] [Related]
10. Relative survival rates after alternative therapies for uveal melanoma.
Seddon JM; Gragoudas ES; Egan KM; Glynn RJ; Howard S; Fante RG; Albert DM
Ophthalmology; 1990 Jun; 97(6):769-77. PubMed ID: 2374681
[TBL] [Abstract][Full Text] [Related]
11. Local recurrence after uveal melanoma proton beam therapy: recurrence types and prognostic consequences.
Caujolle JP; Paoli V; Chamorey E; Maschi C; Baillif S; Herault J; Gastaud P; Hannoun-Levi JM
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1218-24. PubMed ID: 23177670
[TBL] [Abstract][Full Text] [Related]
12. Posterior uveal melanoma treated with I-125 brachytherapy or primary enucleation.
Krohn J; Monge OR; Skorpen TN; Mørk SJ; Dahl O
Eye (Lond); 2008 Nov; 22(11):1398-403. PubMed ID: 17585309
[TBL] [Abstract][Full Text] [Related]
13. Uveal melanoma recurrence after fractionated proton beam therapy: comparison of survival in patients treated with reirradiation or with enucleation.
Marucci L; Ancukiewicz M; Lane AM; Collier JM; Gragoudas ES; Munzenrider JE
Int J Radiat Oncol Biol Phys; 2011 Mar; 79(3):842-6. PubMed ID: 20472356
[TBL] [Abstract][Full Text] [Related]
14. Local Recurrence After Primary Proton Beam Therapy in Uveal Melanoma: Risk Factors, Retreatment Approaches, and Outcome.
Seibel I; Cordini D; Rehak M; Hager A; Riechardt AI; Böker A; Heufelder J; Weber A; Gollrad J; Besserer A; Joussen AM
Am J Ophthalmol; 2015 Oct; 160(4):628-36. PubMed ID: 26133249
[TBL] [Abstract][Full Text] [Related]
15. Histopathology of proton beam-irradiated vs enucleated uveal melanomas.
Saornil MA; Egan KM; Gragoudas ES; Seddon JM; Walsh SM; Albert DM
Arch Ophthalmol; 1992 Aug; 110(8):1112-8. PubMed ID: 1323252
[TBL] [Abstract][Full Text] [Related]
16. Evidence-based estimates of outcome in patients irradiated for intraocular melanoma.
Gragoudas E; Li W; Goitein M; Lane AM; Munzenrider JE; Egan KM
Arch Ophthalmol; 2002 Dec; 120(12):1665-71. PubMed ID: 12470140
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant proton beam irradiation followed by transscleral resection of uveal melanoma in 106 cases.
Willerding GD; Cordini D; Moser L; Krause L; Foerster MH; Bechrakis NE
Br J Ophthalmol; 2016 Apr; 100(4):463-7. PubMed ID: 26224096
[TBL] [Abstract][Full Text] [Related]
18. Current results of proton beam irradiation of uveal melanomas.
Gragoudas ES; Seddon J; Goitein M; Verhey L; Munzenrider J; Urie M; Suit HD; Blitzer P; Koehler A
Ophthalmology; 1985 Feb; 92(2):284-91. PubMed ID: 2984625
[TBL] [Abstract][Full Text] [Related]
19. Proton beam irradiation of uveal melanomas. Results of 5 1/2-year study.
Gragoudas ES; Goitein M; Verhey L; Munzenreider J; Urie M; Suit H; Koehler A
Arch Ophthalmol; 1982 Jun; 100(6):928-34. PubMed ID: 6284097
[TBL] [Abstract][Full Text] [Related]
20. Eye retention after proton beam radiotherapy for uveal melanoma.
Egger E; Zografos L; Schalenbourg A; Beati D; Böhringer T; Chamot L; Goitein G
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):867-80. PubMed ID: 12605964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
